Differences in cellular function and viral protein expression between IgMhigh and IgMlow B-cells in bovine leukemia

Ryoyo Ikebuchi1, Satoru Konnai1, Tomohiro Okagawa1

  • 1Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.

Insights

Bovine leukemia virus (BLV) infects B-cells in cattle, leading to lymphoma. This study identifies IgM(high) B-cells as primarily BLV-expressing and IgM(low) B-cells as BLV-silencing, offering new diagnostic markers.

Area of Science:

  • Veterinary Virology
  • Immunology
  • Oncology

Background:

  • Bovine leukemia virus (BLV) causes B-cell proliferation and lymphoma in cattle.
  • BLV provirus integrates into the host genome, but viral protein expression is typically low in vivo.
  • BLV-infected B-cells exist in both silencing and expressing states, with unclear differentiation mechanisms.

Purpose of the Study:

  • To identify markers distinguishing BLV-expressing from BLV-silencing B-cells in infected cattle.
  • To characterize cellular behavior and gene expression differences between these B-cell subsets.

Main Methods:

  • Analysis of B-cell markers and viral antigen expression in blood lymphocytes from BLV-infected cattle.
  • Flow cytometry to quantify IgM(high) and IgM(low) B-cell populations.
  • Real-time PCR and microarray analysis to assess proto-oncogene expression.
  • Examination of B-cell subsets in lymphoma tissues.

Main Results:

  • Proportions of IgM(high) B-cells increased in BLV-infected cattle.
  • IgM(high) B-cells predominantly expressed BLV antigens, while IgM(low) B-cells did not, despite equivalent provirus loads.
  • IgM(low) B-cells showed higher expression of proto-oncogenes like Maf, Jun, and Fos compared to IgM(high) B-cells.
  • Lymphoma cells were exclusively IgM(low) or IgM(-).

Conclusions:

  • IgM(high) B-cells are primarily BLV-expressing cells.
  • IgM(low) B-cells represent a significant population of BLV-silencing cells.
  • This differentiation based on IgM expression provides a potential marker for BLV-infected B-cell subsets and disease progression.